Michael Lanthier
Impact in
- Economics and Econometrics top 5%
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Statistics and Probability top 5%
- Statistical Methods in Clinical Trials
Papers in
-
- Pharmaceutical Economics and Policy 10
- Health Systems, Economic Evaluations, Quality of Life 4
-
- Biosimilars and Bioanalytical Methods 4
- Co-authors
- Kathleen L. Miller (7 shared papers)Clark Nardinelli (3 shared papers)Rachel E. Sherman (1 shared paper)Hala Shamsuddin (1 shared paper)Leonard Sacks (1 shared paper)Janet Woodcock (2 shared papers)Rachel E. Behrman (1 shared paper)John Farley (1 shared paper)
- Journals
- Health Affairs (3 papers)Nature Reviews Drug Discovery (2 papers)JAMA (1 paper)Clinical Infectious Diseases (1 paper)Drug Safety (1 paper)
- Partner nations
- United StatesThailandIsrael
In The Last Decade
Michael Lanthier
12 papers receiving 425 citations
Peers
Comparison fields: 5 of 93
- Economics and Econometrics 213
- Statistics and Probability 59
- Toxicology 23
- Applied Microbiology and Biotechnology 10
- Pharmacology 42
Countries citing papers authored by Michael Lanthier
This map shows the geographic impact of Michael Lanthier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lanthier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lanthier more than expected).
Fields of papers citing papers by Michael Lanthier
This network shows the impact of papers produced by Michael Lanthier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lanthier. The network helps show where Michael Lanthier may publish in the future.
Co-authors
The 14 scholars most cited alongside Michael Lanthier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 153 | |
| 2 | 2013 | 91 | |
| 3 | 2020 | 37 | |
| 4 | 2008 | 36 | |
| 5 | 2017 | 30 | |
| 6 | 2018 | 30 | |
| 7 | 2015 | 29 | |
| 8 | 2016 | 26 | |
| 9 | 2019 | 8 | |
| 10 | 2024 | 5 | |
| 11 | 2003 | 2 | |
| 12 | War Widows and the Expansion of the French Welfare State | 2003 | 1 |
About Michael Lanthier
Michael Lanthier is a scholar working on Economics and Econometrics, Immunology, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Management of Technology and Innovation, having authored 12 papers that have together received 448 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (10 papers), Biosimilars and Bioanalytical Methods (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical studies and practices (3 papers), Biotechnology and Related Fields (3 papers), Intellectual Property and Patents (2 papers), Statistical Methods in Clinical Trials (2 papers) and Pharmacovigilance and Adverse Drug Reactions (1 paper). The work is most often cited by research in Economics and Econometrics (213 citations), Statistics and Probability (59 citations), Toxicology (23 citations), Applied Microbiology and Biotechnology (10 citations) and Pharmacology (42 citations). Michael Lanthier has collaborated with scholars based in United States, Thailand and Israel. Frequent co-authors include Kathleen L. Miller, Clark Nardinelli, Rachel E. Sherman, Hala Shamsuddin, Leonard Sacks, Janet Woodcock, Rachel E. Behrman, John Farley, Edward Cox and Gerald J. Dal Pan. Their work appears in journals such as Health Affairs, Nature Reviews Drug Discovery, JAMA, Clinical Infectious Diseases and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.